BARD1 carriers favor the development of high-grade invasion breast cancer, the same as BRCA1 carriers (p-value = 0.204), while BRCA2 carriers and non-carriers develops less aggressive tumors (p-values = 0.004 and <0.001 respectively). This evidence concerns the gene BRCA2 and breast cancer.